866-997-4948(US-Canada Toll Free)

Endonovo Therapeutics Inc (ENDV) - Product Pipeline Analysis, 2018 Update

Published By :

GlobalData

Published Date : Dec 2018

Category :

Pharmaceutical

No. of Pages : 39 Pages

Summary

Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The companys products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Its Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. Endonovo Therapeutics pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders such as acute concussions, post-concussion syndrome, ischemic heart disease, traumatic brain injury and multiple sclerosis. The companys Electroceuticals are electronic devices designed to affect biological systems to alleviate or mitigate symptomatology and pathology. Endonovo Therapeutics is headquartered in Woodland Hills, California, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Endonovo Therapeutics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Endonovo Therapeutics Inc Company Overview 5
Endonovo Therapeutics Inc Company Snapshot 5
Endonovo Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Endonovo Therapeutics Inc Pipeline Analysis Overview 8
Endonovo Therapeutics Inc - Key Facts 8
Endonovo Therapeutics Inc - Major Products and Services 9
Endonovo Therapeutics Inc Pipeline Products by Development Stage 10
Endonovo Therapeutics Inc Ongoing Clinical Trials by Trial Status 12
Endonovo Therapeutics Inc Pipeline Products Overview 14
Bioelectronic Device - Acute Kidney Injury 14
Bioelectronic Device - Acute Kidney Injury Product Overview 14
Bioelectronic Device - Acute Myocardial Infarction 15
Bioelectronic Device - Acute Myocardial Infarction Product Overview 15
Bioelectronic Device - Fulminant Liver Failure 16
Bioelectronic Device - Fulminant Liver Failure Product Overview 16
Bioelectronic Device - Urinary Incontinence 17
Bioelectronic Device - Urinary Incontinence Product Overview 17
DSF-rTMS 18
DSF-rTMS Product Overview 18
Multi-Coil Transcranial Magnetic Stimulation System 19
Multi-Coil Transcranial Magnetic Stimulation System Product Overview 19
Non-Invasive Electroceutical Device - CKD 20
Non-Invasive Electroceutical Device - CKD Product Overview 20
Non-Invasive Electroceutical Device - CLI 21
Non-Invasive Electroceutical Device - CLI Product Overview 21
Non-Invasive Electroceutical Device - CLI Clinical Trial 22
Non-Invasive Electroceutical Device - NASH 23
Non-Invasive Electroceutical Device - NASH Product Overview 23
SofPulse 24
SofPulse Product Overview 24
SofPulse Clinical Trial 25
Endonovo Therapeutics Inc - Key Competitors 26
Endonovo Therapeutics Inc - Key Employees 27
Endonovo Therapeutics Inc - Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Endonovo Therapeutics Inc, Recent Developments 29
Jun 14, 2018: Endonovo Therapeutics Announces Enrollment of First Patient in Clinical Study at the University of New Mexico for Treating Traumatic Brain Injury Using Its Electroceutical Therapy 29
May 09, 2018: Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical SofPulse 29
May 01, 2018: Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients 30
Apr 19, 2018: Flowsion Wins Horizon 2020 SME Instrument Grant for Automatic Glucose Control in Intensive Care Medicine 30
Feb 12, 2018: Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device 31
Feb 01, 2018: Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction 31
Jan 22, 2018: Endonovo Announces First Commercial Sales for SofPulse Wearable Electroceutical for Post-Operative Pain and Edema 32
Jan 16, 2018: Endonovo Therapeutics Provides Corporate Update and 2018 Outlook 33
Oct 13, 2017: Endonovo Receives Positive Results from Pre-Clinical Study of Non-Invasive Electroceutical 34
Sep 26, 2017: Endonovo Therapeutics Provides Update on Pre-Clinical Studies 35
Appendix 36
Methodology 36
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Endonovo Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Endonovo Therapeutics Inc Pipeline Products by Equipment Type 6
Endonovo Therapeutics Inc Pipeline Products by Indication 7
Endonovo Therapeutics Inc Ongoing Clinical Trials by Trial Status 7
Endonovo Therapeutics Inc, Key Facts 8
Endonovo Therapeutics Inc, Major Products and Services 9
Endonovo Therapeutics Inc Number of Pipeline Products by Development Stage 10
Endonovo Therapeutics Inc Pipeline Products Summary by Development Stage 11
Endonovo Therapeutics Inc Ongoing Clinical Trials by Trial Status 12
Endonovo Therapeutics Inc Ongoing Clinical Trials Summary 13
Bioelectronic Device - Acute Kidney Injury - Product Status 14
Bioelectronic Device - Acute Kidney Injury - Product Description 14
Bioelectronic Device - Acute Myocardial Infarction - Product Status 15
Bioelectronic Device - Acute Myocardial Infarction - Product Description 15
Bioelectronic Device - Fulminant Liver Failure - Product Status 16
Bioelectronic Device - Fulminant Liver Failure - Product Description 16
Bioelectronic Device - Urinary Incontinence - Product Status 17
Bioelectronic Device - Urinary Incontinence - Product Description 17
DSF-rTMS - Product Status 18
DSF-rTMS - Product Description 18
Multi-Coil Transcranial Magnetic Stimulation System - Product Status 19
Multi-Coil Transcranial Magnetic Stimulation System - Product Description 19
Non-Invasive Electroceutical Device - CKD - Product Status 20
Non-Invasive Electroceutical Device - CKD - Product Description 20
Non-Invasive Electroceutical Device - CLI - Product Status 21
Non-Invasive Electroceutical Device - CLI - Product Description 21
Non-Invasive Electroceutical Device - CLI - A Clinical Study to Evaluate the Effect of Non-Invasive Electroceutical Device in the Treatment of Traumatic Brain Injury 22
Non-Invasive Electroceutical Device - NASH - Product Status 23
Non-Invasive Electroceutical Device - NASH - Product Description 23
SofPulse - Product Status 24
SofPulse - Product Description 24
SofPulse - A Comparison of Pulsed Electromagnetic Fields (PEMF) and Pectoral (PEC) Interfascial Blocks on Postoperative Pain Reduction in Patients Undergoing Mastectomy and Tissue Expander Reconstruction 25
SofPulse - Effect of Pulsed Electromagnetic Field Therapy on Pain after Cesarean Delivery 25
SofPulse - NSI PEMF Biomarker Study: 14-113 Nemoto 25
Endonovo Therapeutics Inc, Key Employees 27
Glossary 38

List of Figures
Endonovo Therapeutics Inc Pipeline Products by Equipment Type 6
Endonovo Therapeutics Inc Pipeline Products by Development Stage 10
Endonovo Therapeutics Inc Ongoing Clinical Trials by Trial Status 12

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *